5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord Disorders
NCT ID: NCT06302478
Last Updated: 2024-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
42 participants
INTERVENTIONAL
2024-03-12
2024-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Will participants receiving the 5E program have lower rates of venous thromboembolism compared to those receiving the usual care?
* Will participants receiving the 5E program have lower scores of venous thromboembolism signs and symptoms compared to those receiving the usual care?
* Will the average thigh and calf circumferences of participants before and after receiving the 5E program be different?
Participants in the intervention group will receive the 5E program, including
* Education: health education regarding venous thromboembolism prevention
* Elevation: leg elevation of 10-20 degrees
* Exercise: ankle exercises
* Enough fluid: adequate fluid uptake
* Early application of intermittent pneumatic compression (IPC): IPC use within 48 hours after admission
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidural Stimulation After Neurologic Damage
NCT03026816
Assessment of the Effects of Early Proprioceptive Stimulations in Patients With Spinal Cord Injury
NCT05094752
Hybrid-FES Exercise to Prevent Cardiovascular Declines in Acute SCI
NCT02139436
Multidisciplinary Teamwork Perceptions When Mobilizing Ventilated Neurosurgery Patients
NCT05583487
Early FES Cycling in Acute Spinal Cord Injury for Neuromuscular Preservation and Neurorecovery
NCT05255679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SEQUENTIAL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5E Program
Participants in the 5E program group will receive 7-day nursing interventions.
5E program
Participants in the 5E program group will receive 7-day nursing interventions including
* Education: health education regarding venous thromboembolism prevention
* Elevation: leg elevation of 10-20 degrees
* Exercise: ankle exercises
* Enough fluid: adequate fluid uptake
* Early application of intermittent pneumatic compression (IPC): IPC use within 48 hours after admission
Usual Care
Participants in the control group will receive 7-day usual care interventions, including health education regarding signs and symptoms of venous thromboembolism and IPC use if the participants experienced muscle power as grade 0.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
5E program
Participants in the 5E program group will receive 7-day nursing interventions including
* Education: health education regarding venous thromboembolism prevention
* Elevation: leg elevation of 10-20 degrees
* Exercise: ankle exercises
* Enough fluid: adequate fluid uptake
* Early application of intermittent pneumatic compression (IPC): IPC use within 48 hours after admission
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to communicate in the Thai language
* Willing to participate in this study
Exclusion Criteria
* Experiencing complications, including neurogenic shock and autonomic dysreflexia
* Being pregnant
* Having fluid restriction
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Khon Kaen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wiphawadee Potisopha
Principle Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chaiyaphum Hospital
Chaiyaphum, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KhonKaenU001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.